强生（纽约证券交易所代码：JNJ）平均寄送分析师的 “适度买入” 推荐

:JNJ – Get Rating) last announced its earnings results on Tuesday, October 18th. The company reported $2.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.49 by $0.06. Johnson Price Johnson had a net margin of 19.95% and a return on equity of 35.37%. The company had revenue of $23.79 billion for the quarter, compared to ysts' expectations of $23.44 billion. During the same quarter in the previous year, the company posted $2.60 EPS. The firm's quarterly revenue was up 1.9% on a year-over-year basis. As a group, equities research ysts anticipate that Johnson Price Johnson will post 10.04 earnings per share for the current fiscal year.

Johnson Price Johnson Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 7th. Stockholders of record on Tuesday, February 21st will be issued a $1.13 dividend. The ex-dividend date of this dividend is Friday, February 17th. This represents a $4.52 dividend on an annualized basis and a dividend yield of 2.62%. Johnson Price Johnson's payout ratio is 62.95%.

Insider Buying and Selling

In other Johnson Price Johnson news, EVP Ashley Mcevoy sold 73,323 shares of the company's stock in a transaction that occurred on Wednesday, November 30th. The stock was sold at an erage price of $175.47, for a total transaction of $12,865,986.81. Following the completion of the sale, the executive vice president now directly owns 41,813 shares of the company's stock, valued at approximately $7,336,927.11. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, VP Peter Fasolo sold 29,275 shares of the stock in a transaction that occurred on Monday, October 24th. The stock was sold at an erage price of $171.36, for a total transaction of $5,016,564.00. Following the completion of the transaction, the vice president now directly owns 114,676 shares of the company's stock, valued at approximately $19,650,879.36. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Ashley Mcevoy sold 73,323 shares of the firm's stock in a transaction that occurred on Wednesday, November 30th. The shares were sold at an erage price of $175.47, for a total value of $12,865,986.81. Following the completion of the transaction, the executive vice president now directly owns 41,813 shares of the company's stock, valued at $7,336,927.11. The disclosure for this sale can be found here. Insiders sold a total of 277,886 shares of company stock worth $48,550,549 in the last 90 days. Company insiders own 0.35% of the company's stock.

Institutional Investors Weigh In On Johnson Price Johnson

Several hedge funds he recently made changes to their positions in the business. Global Wealth Strategies Price Associates purchased a new position in Johnson Price Johnson in the fourth quarter valued at about $140,000. Diversified Trust Co grew its holdings in Johnson Price Johnson by 10.5% during the 4th quarter. Diversified Trust Co now owns 130,708 shares of the company's stock worth $23,090,000 after acquiring an additional 12,381 shares in the last quarter. Lowe Wealth Advisors LLC raised its stake in shares of Johnson Price Johnson by 15.5% in the 4th quarter. Lowe Wealth Advisors LLC now owns 1,134 shares of the company's stock valued at $200,000 after purchasing an additional 152 shares in the last quarter. AHL Investment Management Inc. grew its stake in Johnson Price Johnson by 4.7% in the fourth quarter. AHL Investment Management Inc. now owns 13,934 shares of the company's stock worth $2,461,000 after purchasing an additional 621 shares in the last quarter. Finally, Steigerwald Gordon Price Koch Inc. grew its stake in Johnson Price Johnson by 2.3% in the fourth quarter. Steigerwald Gordon Price Koch Inc. now owns 95,949 shares of the company's stock worth $16,949,000 after purchasing an additional 2,145 shares in the last quarter. Institutional investors and hedge funds own 67.94% of the company's stock.

About Johnson Price Johnson

(Get Rating)

Johnson Price Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN Price CLEAR, DR.

Read More

Get a free copy of the StockNews.com research report on Johnson Price Johnson (JNJ)Cathie Wood Is Buying These Stocks, Should You?Thor Industries Hammered Its Numbers. Is it a Buy?Tritium Is the Largest DC EV Charger Maker You've Never Heard Of United Airlines Soars Ahead of Earnings...Time to Deplane?Is Dividend King PPG Industries A Buy Before Earnings?Receive News Price Ratings for Johnson Price Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and ysts' ratings for Johnson Price Johnson and related companies with MarketBeat.com's FREE daily email newsletter.

。

麝香壮骨膏可以跟安必丁一起用吗
哈萨克斯坦做一次试管婴儿多少钱
肠炎宁片治疗拉肚子有用吗
胃经常反酸烧心是怎么回事
喝酒过后经常腹泻是什么原因